Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 931 AL 945

Can rapamycin slow down memory decline in Alzheimer's disease with seizures?

Shetty AK.

Brain. 2022 Mar 29;145(1):14-16. doi: 10.1093/brain/awab474.

Blood mRNA Expression in Alzheimer's Disease and Dementia With Lewy Bodies

Donaghy PC, Cockell SJ, Martin-Ruiz C, Coxhead J, Kane J, Erskine D, Koss D, Taylor JP, Morris CM, O'Brien JT, Thomas AJ.

Am J Geriatr Psychiatry. 2022 Sep;30(9):964-975. doi: 10.1016/j.jagp.2022.02.003. Epub 2022 Feb 12.

Reactive gliosis in Alzheimer's disease: a crucial role for cognitive impairment and memory loss

De Sousa RAL.

Metab Brain Dis. 2022 Apr;37(4):851-857. doi: 10.1007/s11011-022-00953-2. Epub 2022 Mar 14.

The effect of metformin on cognitive function: A systematic review and meta-analysis

Tabatabaei Malazy O, Bandarian F, Qorbani M, Mohseni S, Mirsadeghi S, Peimani M, Larijani B.

J Psychopharmacol. 2022 Jun;36(6):666-679. doi: 10.1177/02698811211057304. Epub 2022 Mar 17.

Potential for non-starch polysaccharides in the prevention and remediation of cognitive impairment: A comprehensive review

Rang Y, Liu H, Liu C.

Int J Biol Macromol. 2022 May 31;208:182-195. doi: 10.1016/j.ijbiomac.2022.03.065. Epub 2022 Mar 14.

Central Auditory Functions of Alzheimer's Disease and Its Preclinical Stages: A Systematic Review and Meta-Analysis

Tarawneh HY, Menegola HK, Peou A, Tarawneh H, Jayakody DMP.

Cells. 2022 Mar 16;11(6):1007. doi: 10.3390/cells11061007.

Theta and gamma oscillatory dynamics in mouse models of Alzheimer's disease: A path to prospective therapeutic intervention

Mehak SF, Shivakumar AB, Kumari S, Muralidharan B, Gangadharan G.

Neurosci Biobehav Rev. 2022 May;136:104628. doi: 10.1016/j.neubiorev.2022.104628. Epub 2022 Mar 22.

Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients

Pichet Binette A, Palmqvist S, Bali D, Farrar G, Buckley CJ, Wolk DA, Zetterberg H, Blennow K, Janelidze S, Hansson O.

Alzheimers Res Ther. 2022 Mar 29;14(1):46. doi: 10.1186/s13195-022-00990-0.

Flavonoids: The Innocuous Agents Offering Protection against Alzheimer's Disease Through Modulation of Proinflammatory and Apoptotic Pathways

Biswas M, Das A, Basu S.

Curr Top Med Chem. 2022;22(9):769-789. doi: 10.2174/1568026622666220330011645.

The Role of Resveratrol in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review

Buglio DS, Marton LT, Laurindo LF, Guiguer EL, Araújo AC, Buchaim RL, Goulart RA, Rubira CJ, Barbalho SM.

J Med Food. 2022 Aug;25(8):797-806. doi: 10.1089/jmf.2021.0084. Epub 2022 Mar 28.

Artificial intelligence in brain MRI analysis of Alzheimer's disease over the past 12 years: A systematic review

Frizzell TO, Glashutter M, Liu CC, Zeng A, Pan D, Hajra SG, D'Arcy RCN, Song X.

Ageing Res Rev. 2022 May;77:101614. doi: 10.1016/j.arr.2022.101614. Epub 2022 Mar 28.

The past, present, and future of sleep measurement in mild cognitive impairment and early dementia-towards a core outcome set: a scoping review

Blackman J, Morrison HD, Lloyd K, Gimson A, Banerjee LV, Green S, Cousins R, Rudd S, Harding S, Coulthard E.

Sleep. 2022 Jul 11;45(7):zsac077. doi: 10.1093/sleep/zsac077.

Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysis

Eikelboom WS, Pan M, Ossenkoppele R, Coesmans M, Gatchel JR, Ismail Z, Lanctôt KL, Fischer CE, Mortby ME, van den Berg E, Papma JM.

Alzheimers Res Ther. 2022 Apr 4;14(1):48. doi: 10.1186/s13195-022-00991-z.

What's the cut-point?: a systematic investigation of tau PET thresholding methods

Weigand AJ, Maass A, Eglit GL, Bondi MW.

Alzheimers Res Ther. 2022 Apr 5;14(1):49. doi: 10.1186/s13195-022-00986-w.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias